Immuno-oncology and the classification of subtypes of gastric cancer could greatly advance treatment efficacy and variation, according to Manish A. Shah, MD. – See more at: http://www.targetedonc.com/news/new-drugs-immunooncology-advances-gastric-cancer-treatment-paradigm#sthash.Nr1A9rBl.dpuf
http://www.targetedonc.com/news/new-drugs-immunooncology-advances-gastric-cancer-treatment-paradigm
New Drugs, Immuno-Oncology Advances Gastric Cancer Treatment Paradigm